Sony Corporation

Mochida Pharmaceutical Co., Ltd.

Sekisui Medical Co., Ltd.

Sony Semiconductor Solutions Corporation

Kowa Company Limited

Nissan Chemical Industries Limited

Eisai Company, Limited

Eisai R&d Management Co., Ltd.

Mochida Pharmaceutical., Ltd.

Yasushi Saito

Yuji Matsuzawa

Masunori Matsuzaki

Hideki Origasa

Mitsuhiro Yokoyama

Hiroyuki Ebinuma

Hideaki Bujo

Isamu Fukamachi

Tomoo Mitsunaga

Isao Hirota

Kohei Takubo

Shinichi Oikawa

Yuichi Ishikawa

Shun Kaizu

Masanori Kasai

Masashi Ito

Hiroshige Itakura

Toru Kita

Mitsuhiko Awata

Masanao Matsuo

Akira Kitabatake

Noriaki Nakaya

Toshiie Sakata

Kazuyuki Shimada

Kunio Shirato

Chiaki Nakaseko

Jun Sasaki

Hitoshi Hishida

Hiroaki Ono

Masaki Kitahara

Teppei Kurita

Atsushi Yamanaka

Tetsuhiro Shiomi

Toru Nishi

Masahiko Ohta

Mitsuaki Sakashita

Akio Iwasaki

Fumihito Yasuma

Ryuji Takeda

Daisuke Kawamata

Ryo Hirono

Satoru Takeuchi

Takahiro Komazaki

Tomoya Takeda

Hiroyuki Yamazaki

Seiichiro Oishi

Koichi Arai

Saishu Yoshida

Toshie Shibazaki

Kyomi Toyoda

Provided is a solid state imaging device including: a pixel array in which pixels are disposed on a matrix; an iris authenticator that extracts iris information to be used in an iris authentication process, from image data obtained from the pixel array through photoelectric conversion; and an imaging condition controller that performs control to set an imaging condition in obtaining the image data for the iris authentication process, by using information obtained in a process of extracting the iris information.

Solid state imaging device and method of controlling solid state imaging device

Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with HMG-CoA RI or a cardiovascular event occurring in a multiple risk patient.

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

Provided is a signal processing device, including a pixel array unit configured to include first pixels, second pixels, third pixels, and fourth pixels which have different spectral sensitivity characteristics and are arranged in a matrix form; and a pixel signal reading unit configured to read pixel signals obtained from the plurality of pixels arranged in the pixel array unit. The first pixels are adjacent to the second pixels in a row direction and a column direction, the second pixels are arranged at a two-pixel pitch in the row direction and the column direction, the third pixels are adjacent to the second pixels in one diagonal direction, the fourth pixels are adjacent to the second pixels in the other diagonal direction, and the pixel signal reading unit adds and reads the pixel signals obtained from the plurality of first pixels.

Signal processing device and signal processing method

Provided is a detection method for a malignant tumor cell, including measuring a protein marker expressed on a malignant tumor cell surface. The detection method for a malignant tumor cell includes measuring LR11 on a cell surface in a sample to be tested.

Method for detecting malignant tumor cells

To provide an apparatus that generates an RGB pattern data from an image pickup signal by an image pickup element having an RGBW pattern and a method. An edge detection unit analyzes an output signal of the image pickup signal of the RGBW pattern to obtain edge information corresponding to the respective pixels, and a texture detection unit generates texture information. Furthermore, a parameter calculation unit executes an interpolation processing in which an applied pixel position is changed in accordance with an edge direction of a transform target pixel to generate parameters equivalent to an interpolation pixel value. In a blend processing unit, the parameters generated by the parameter calculation unit, the edge information, and the texture information are input, in accordance with the edge information and the texture information corresponding to the transform pixel, a blend ratio of the parameters calculated by the parameter calculation unit is changed, the blend processing is executed, and a transform pixel value is decided.

Image processing apparatus and image processing method, and program

A medical composition for reducing the rate of new-onset diabetes caused by administration of a statin or for inhibiting an increase in blood glucose level by administration of a statin, the composition containing at least one ingredient selected from the group consisting of icosapentaenoic acid and pharmaceutically acceptable salts or esters thereof as an inactive ingredient.

Composition for reducing new-onset diabetes

There are provided a device and method that correct a false color occurring in a locally highlighted region in an image. A false color pixel is detected in data conversion processing of generating an RGB array image from an RGBW array image, low-band signals corresponding to respective RGBW colors that are different according to whether a pixel is a false color pixel, and the RGBW array is converted by interpolation processing to which the calculated low-band signals are applied to generate the RGB array image. The interpolation processing is performed using the low-band signals on an assumption that a W low-band signal mW, and RGB respective low-band signals mR, mG, and mB have a proportional relation in a local region. When a pixel of interest is a false color pixel, the low-band signal is calculated by an application of a low-pass filter having a coefficient in which a contribute rate of pixel values in the vicinity of the pixel of interest is made relatively lower than that of separated pixels.

Image processing device, method of processing image, and image processing program including false color correction

To provide a method for assaying soluble LR11 in a biological sample, which method realizes a simple and accurate assay of soluble LR11 present in the sample by immunological means without requiring isolation of soluble LR11 from the biological sample (e.g., a serum sample). The method of the invention for immunologically assaying soluble LR11 present in a biological sample, characterized in that the method includes treating the sample with at least one surfactant selected from among one or more sulfobetaine amphoteric surfactants and one or more amidosulfobetaine amphoteric surfactants.

Method for immunologically measuring soluble LR11

A solid-state imaging device includes a pixel array unit, a pixel drive unit, and a signal processing unit. The pixel array unit includes first pixels and second pixels, the first pixels corresponding to respective color components of a plurality of color components, the second pixels having luminance components as main components, the first pixels and the second pixels being arranged regularly in a matrix. The pixel drive unit is configured to drive the pixels arranged in the pixel array unit. The signal processing unit is configured to execute predetermined weighted addition processing and calculate a pixel value of an output image by using only pixel information acquired from the first pixels.

Solid-state imaging device, driving method for the same, and electronic apparatus

Provided is a method for quantifying soluble LR11 in a biological sample such as serum by an immunological means conveniently and accurately without the need of carrying out any complicated separation manipulation. An immunological quantification method for soluble LR11 in a sample derived from a mammal, including a step of treating the sample with at least one surfactant selected from a group consisting of a polyoxyalkylene alkyl ether, a polyoxyalkylene alkyl phenyl ether, an alkyl glycoside, an alkylthio glycoside, an acyl-N-methylglucamide and a salt of cholic acid.

Method for quantification of soluble LR 11

By using a composition for preventing onset and/or recurrence of stroke which contains ethyl icosapentate as its effective component, onset and/or recurrence of stroke is prevented, or in particular, the onset and/or recurrence of stroke in a hyperlipidemia patient who has been treated with HMG-CoA RI, or in particular the recurrence of stroke in a patient who is beyond six months after the onset of stroke, is prevented.

Composition and/or method for preventing recurrence of stroke

Provided are composition and/or methods useful in preventing onset and/or recurrence of cardiovascular events, especially in patients who have escaped the unstable period after cardiovascular angioplasty or in hyperlipidemia patients who have been treated with HMG-CoA RI.

Composition and/or method for preventing onset and/or recurrence of cardiovascular events

Provided is an image processing device including a data conversion processing unit that receives an input of an RGBW array image and generates an RGB array image as an output image. The data conversion processing unit includes a pixel interpolation unit that calculates interpolated pixel values corresponding to an array of the RGB array image by performing a pixel interpolation process on the RGBW array image, a purple fringe detection unit that detects whether each pixel is a purple fringe pixel by analyzing the RGBW array image, a corrected value calculation unit that calculates corrected pixel values by correcting pixel values of the purple fringe pixels, and a blend processing unit that calculates constituent pixel values RGB of the output image by performing a blend process of blending the interpolated pixel values calculated by the pixel interpolation unit with the corrected pixel values calculated by the corrected value calculation unit.

Image processing device, image processing method, and program to perform correction processing on a false color

Growing community of inventors

Chiba, Japan

Yasushi Saito